All Posts
Brief Review | Core outcome sets in medical research.
25 Nov, 2022 | 12:22h | UTCCore outcome sets in medical research – BMJ Medicine
Commentary on Twitter
This article sets out the principles of why core outcome sets are needed and provides some information on how medical researchers can select and appraise existing core outcomes. ▶️ https://t.co/LZineBD47F#MedTwitter pic.twitter.com/U1RrIYQBY2
— BMJMedicine (@BMJMedicine) November 17, 2022
Review | Exertional heat stroke: pathophysiology and risk factors.
25 Nov, 2022 | 12:19h | UTCExertional heat stroke: pathophysiology and risk factors – BMJ Medicine
Related:
Classic and exertional heatstroke – Nature Reviews Disease Primers
Treatment and Prevention of Heat-Related Illness – New England Journal of Medicine
Commentary on Twitter
🆕 Review: Exertional heat #stroke ▶️ https://t.co/nJwjDaxxiD@olaitano#MedTwitter pic.twitter.com/eSIOPcjk1E
— BMJMedicine (@BMJMedicine) November 11, 2022
Clinical questions in primary care: where to find the answers – A cross-sectional study.
25 Nov, 2022 | 12:17h | UTCClinical questions in primary care: Where to find the answers – a cross-sectional study – PLOS One
M-A | Risk of cardiovascular diseases associated with medications used in ADHD.
25 Nov, 2022 | 12:16h | UTCCommentaries:
Meta-Analysis Finds ADHD Drugs Not Linked To Risk Of Cardiovascular Disease – Reporter Health
WHO report highlights oral health neglect affecting nearly half of the world’s population.
24 Nov, 2022 | 13:36h | UTCNews Release: WHO highlights oral health neglect affecting nearly half of the world’s population – World Health Organization
Commentary: Oral Health Neglect: The Overlooked Crisis Affecting 3.5 Billion People – Health Policy Watch
Commentary on Twitter (thread – click for more)
Good #OralHealth is essential in our daily lives helping us eat, breathe, and speak.
Yet, oral diseases affect nearly 3.5 billion people worldwide. More in WHO’s new Global Oral Health Status Report 👉https://t.co/NYOvKYy6Xg pic.twitter.com/zpyI2uqWfT
— World Health Organization (WHO) (@WHO) November 18, 2022
WHO updates recommendations to guide family planning decisions.
24 Nov, 2022 | 13:38h | UTCNews Release: WHO updates recommendations to guide family planning decisions – World Health Organization
Family planning: A global handbook for providers – World Health Organization (PDF)
Commentary on Twitter (thread – click for more)
👉WHO releases important updates to its Family Planning Handbook 🔖
⏭providing health workers and policymakers with the most updated information on contraceptive options.
Know more:🔗https://t.co/UhC1BFca2r pic.twitter.com/LQEtm3wmbZ
— World Health Organization (WHO) (@WHO) November 15, 2022
RCT | Anticoagulation for 3 months reduces recurrence rates vs. treatment for 6 weeks in patients with isolated distal DVT.
24 Nov, 2022 | 13:34h | UTCNews Release: Extending anti-clotting treatment after distal DVT reduces further clot risk – BMJ Newsroom
Review | Climate change and vectorborne diseases.
24 Nov, 2022 | 13:31h | UTCClimate Change and Vectorborne Diseases – New England Journal of Medicine
Commentary on Twitter
Warming temperatures and changes in precipitation associated with climate change are affecting the occurrence of vectorborne diseases. Effective, equitable strategies are needed for vector control and disease management. https://t.co/o1yUTkjs93 pic.twitter.com/4Qn4RRXBcL
— NEJM (@NEJM) November 23, 2022
Review | Psychiatric issues among health professionals.
24 Nov, 2022 | 13:29h | UTCPsychiatric Issues Among Health Professionals – Medical Clinics of North America
Review | Care of the seriously ill patient with SARS-CoV-2.
24 Nov, 2022 | 13:26h | UTCCare of the Seriously Ill Patient with SARS-CoV-2 – Medical Clinics of North America
SR | Surgical decompression for malignant cerebral edema after ischemic stroke.
24 Nov, 2022 | 13:25h | UTCSurgical decompression for malignant cerebral oedema after ischaemic stroke – Cochrane Library
Summary: Surgical decompression for people with severe brain swelling after stroke – Cochrane Library
SR | Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
24 Nov, 2022 | 13:21h | UTC
SR | Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
24 Nov, 2022 | 13:24h | UTC
M-A | Prevalence and global estimates of unsafe listening practices in adolescents and young adults.
24 Nov, 2022 | 13:18h | UTCNews Release: 1 billion + young people potentially at risk of hearing loss from loud music – BMJ Newsroom
Commentary from the author on Twitter (with video summary).
Why risk your hearing when its possible to ‘hear for life’?
Listen with care! @WHO study shows that 1 billion young people risk hearing loss from loud music. https://t.co/ziDn5OOoJn
protect your ears by following simple tips for #safelistening @MikkelsenBente_ pic.twitter.com/jvMVGXDpPi— Shelly Chadha (@ShellyChadha1) November 22, 2022
RCT | Low-dose morphine did not significantly reduce the intensity of chronic breathlessness in patients with COPD.
23 Nov, 2022 | 14:09h | UTCEffect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Dyspnea—When a Sensation Becomes a Symptom – JAMA (free for a limited period)
See also: Visual Abstract
Commentary: Breathlessness in Patients with COPD isn’t Reduced with Daily Morphine – HCP Live
KDIGO 2022 Guideline for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease.
23 Nov, 2022 | 14:11h | UTCExecutive Summary: KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease – Kidney International
Guideline Synopsis | Diagnosis and treatment of infertility in men.
23 Nov, 2022 | 14:08h | UTCDiagnosis and Treatment of Infertility in Men – JAMA (free for a limited period)
Original Guideline: AUA/ASRM Guideline: Diagnosis and treatment of infertility in men
RCT | Treatment of early Lyme Disease with doxycycline for 7 days is noninferior to treatment for 14 days.
23 Nov, 2022 | 14:06h | UTCTreatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Commentary: Shorter Duration of Antibiotics Noninferior for Lyme Disease – JAMA (free for a limited period)
Commentary on Twitter
New research: Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trialhttps://t.co/8lktc4gxzG pic.twitter.com/mP2e0Kn7C5
— The Lancet Infectious Diseases (@TheLancetInfDis) October 7, 2022
RCT | Impact of empagliflozin on decongestion in acute heart failure.
23 Nov, 2022 | 14:04h | UTCCommentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology
Commentary on Twitter
What's the impact of empagliflozin on decongestion in acute heart failure? New insights from the EMPULSE trial in EHJ!https://t.co/O1MZTFPWCc#SGLT2 #decongestion #heartfailure #empagliflozin #cardiotwitter @escardio @ESC_Journals pic.twitter.com/QLJYNgl1Zo
— EHJ Editor-in-Chief (@ehj_ed) October 19, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Cohort Study | Race-dependent association of HDL-C levels with incident coronary artery disease.
23 Nov, 2022 | 14:02h | UTCNews Release: Study challenges “good” cholesterol’s role in universally predicting heart disease risk – National Institutes of Health
Guideline | Screening and assessment of cancer-related fatigue.
23 Nov, 2022 | 13:58h | UTC
RCT | Effects of a physical exercise intervention during vs. after chemotherapy to improve cardiorespiratory fitness.
23 Nov, 2022 | 14:01h | UTCEditorial: Inclusion of Exercise in Cancer Treatment Planning: When Is the Right Time? – JACC: CardioOncology
Commentary: Exercise Intervention During Chemotherapy Beneficial – HealthDay
Cohort Study | Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease.
23 Nov, 2022 | 13:55h | UTCRelated:
AHA Scientific Statement | Polygenic risk scores for cardiovascular disease.
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
Cohort Study: A polygenic risk score may improve risk stratification of coronary artery disease.
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
Commentary on Twitter
A #Polygenic risk score improves the accuracy of a clinical risk score for #CoronaryArteryDisease
Read more about improved predictive accuracy for incident CAD in the #UKBiobank at #BMCMedicine https://t.co/8T5RaacnTj pic.twitter.com/vIhg9IGhRv
— BMC Medicine (@BMCMedicine) November 8, 2022
Cohort Study | Prognostic prediction of genotype vs. phenotype in genetic cardiomyopathies.
23 Nov, 2022 | 13:57h | UTC
Commentary on Twitter
We are out with our last big work on the importance of genotype for the prognostic stratification of Cardiomyopathies! @CardiologyASUGI @Trieste_Denver @JACCJournals @PaldinoAlessia https://t.co/82byVNnUhK pic.twitter.com/KYoxDXkzr6
— matteo dal ferro (@matteodalferro) November 17, 2022
Under a Creative Commons license
Right heart failure in the ED: approach to diagnosis and management.
23 Nov, 2022 | 13:54h | UTCRight Heart Failure in the ED: Approach to Diagnosis and Management – emDocs